United States · Series B startup

Who invested in OrsoBio

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$67Mraised across 1 round since 2024, from 1 source

Latest round
Series B, $67MSept 2024
Investors
3
See who backed them

The rounds

  1. Sept 2024
    Series B$67M

    Source recordedSEC filing: $40M sold, first sale Aug 2024

Everyone who backed them

Eli LillyCorporate VC1round
Samsara BioCapitalVC firm1round
Longitude CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists OrsoBio as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Ascenta CapitalVC firmPer its own site

Quick answers about OrsoBio

Who invested in OrsoBio?

OrsoBio's investors include Eli Lilly, Samsara BioCapital and Longitude Capital.

How much has OrsoBio raised?

OrsoBio has raised $67M across 1 round since 2024.

When did OrsoBio last raise?

OrsoBio's most recent round was a Series B of $67M in Sept 2024.

What was OrsoBio's biggest round?

Its most recent round, $67M in Sept 2024, is also its largest on record.

Who backed OrsoBio first?

OrsoBio's first round on record, in Sept 2024, was backed by Eli Lilly, Samsara BioCapital and Longitude Capital.

What stage is OrsoBio at?

OrsoBio's latest named round is a Series B, in Sept 2024.

Where is OrsoBio based?

OrsoBio is based in the United States.

Companies like OrsoBio

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.